Technical Validation of Lunar iDXA Visceral Fat Tool
Completed
- Conditions
- Obesity
- Interventions
- Device: Visceral fat mass measurement
- First Posted Date
- 2010-04-26
- Last Posted Date
- 2010-12-08
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 148
- Registration Number
- NCT01110161
- Locations
- ๐จ๐ณ
Fudan University Zhongshan Hospital, Shanghai, China
Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus
Phase 3
Terminated
- Conditions
- Normal Pressure Hydrocephalus
- Interventions
- Drug: [18F]Flutemetamol
- First Posted Date
- 2010-03-25
- Last Posted Date
- 2013-12-13
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 12
- Registration Number
- NCT01092546
- Locations
- ๐บ๐ธ
GE Healthcare, Princeton, New Jersey, United States
A Post-Marketing Study for On Label Evaluation of the GE Vscan Ultrasound Imaging System
Completed
- Conditions
- Pulmonary HypertensionRight Ventricular DysfunctionLeft Ventricular DysfunctionHeart Valve Diseases
- First Posted Date
- 2010-02-26
- Last Posted Date
- 2016-03-07
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 1000
- Registration Number
- NCT01076296
- Locations
- ๐บ๐ธ
Oregon Health & Science University, Portland, Oregon, United States
PET Imaging of Brain Amyloid in Normal Pressure Hydrocephalus
- First Posted Date
- 2010-01-21
- Last Posted Date
- 2012-06-11
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 7
- Registration Number
- NCT01053312
- Locations
- ๐บ๐ธ
GE Healthcare, Princeton, New Jersey, United States
Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease
Phase 3
Completed
- Conditions
- Mild Cognitive ImpairmentAlzheimer's Disease
- Interventions
- First Posted Date
- 2009-12-09
- Last Posted Date
- 2014-09-11
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 365
- Registration Number
- NCT01028053
- Locations
- ๐บ๐ธ
GE Healthcare, Princeton, New Jersey, United States
Prevalence of Sleep Disordered Breathing
Terminated
- Conditions
- Unstable AnginaAcute Myocardial InfarctionCongestive Heart Failure
- First Posted Date
- 2009-11-11
- Last Posted Date
- 2012-01-05
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 53
- Registration Number
- NCT01011647
- Locations
- ๐บ๐ธ
Ohio State University Medical Center, Columbus, Ohio, United States
Radiant Warmer Trial
Not Applicable
Withdrawn
- Conditions
- Body Temperature Changes
- Interventions
- Device: GEHC IWS 4400 & Giraffe warmer beds
- First Posted Date
- 2009-11-11
- Last Posted Date
- 2015-09-14
- Lead Sponsor
- GE Healthcare
- Registration Number
- NCT01011855
Single Dose Safety, Tolerance and Pharmacokinetic Study in Healthy Volunteers Undergoing Contrast-enhanced Abdominal Computed Tomography (CT)
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: GE-145 (AN113111) Injection
- First Posted Date
- 2009-10-30
- Last Posted Date
- 2012-04-05
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 50
- Registration Number
- NCT01004770
- Locations
- ๐บ๐ธ
GE Healthcare, Princeton, New Jersey, United States
Trial of Yellow Fever Inactivated Vaccine
Phase 1
Completed
- Conditions
- Yellow Fever
- Interventions
- Biological: XRX-001 Inactivated yellow fever vaccineBiological: Placebo
- First Posted Date
- 2009-10-15
- Last Posted Date
- 2016-05-05
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 60
- Registration Number
- NCT00995865
- Locations
- ๐บ๐ธ
Johnson County Clin-Trials, Lenexa, Kansas, United States
Technical Validation of Lunar iDXA (GE Healthcare) Visceral Fat Tool
Completed
- Conditions
- Obesity
- Interventions
- Device: Visceral fat mass measurement
- First Posted Date
- 2009-09-30
- Last Posted Date
- 2010-12-08
- Lead Sponsor
- GE Healthcare
- Target Recruit Count
- 124
- Registration Number
- NCT00987298
- Locations
- ๐บ๐ธ
Oregon Health & Science University, Portland, Oregon, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath